Clinical Trial Update: Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating the tolerability and safety of FXFM244. It also monitors the clinical effect in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• FXFM244

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED